Company Profile for PharmaNet Development Group, Inc.PharmaNet Development Group, a global, drug development company, provides a comprehensive range of services to the pharmaceutical, biotechnology biotechnology, the use of biological processes, as through the exploitation and manipulation of living organisms or biological systems, in the development or manufacture of a product or in the technological solution to a problem. , generic drug generic drug, a drug sold or prescribed under the nonproprietary name of its active ingredients or under a generally descriptive name rather than under a brand or trade name. and medical device industries. The Company offers clinical-development solutions including early and late stage consulting services Noun 1. consulting service - service provided by a professional advisor (e.g., a lawyer or doctor or CPA etc.) service - work done by one person or group that benefits another; "budget separately for goods and services" , Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately ap·prox·i·mate adj. 1. Almost exact or correct: the approximate time of the accident. 2. 2,200 employees and more than 35 facilities throughout the world, PharmaNet is a recognized leader in outsourced Outsourced is a modern day comedy of cross-cultural conflict and romance, directed by John Jeffcoat, released in 2007. Synopsis Todd Anderson (Josh Hamilton) spends his days managing a customer call center for American Novelty Products in Seattle, until his job, clinical development. For more information, please visit our website at www.pharmanet.com.
Company: <
PharmaNet Development Group, Inc.
<
Headquarters Address: <
504 Carnegie Center
<
Princeton, NJ 08540
<
Main Telephone: <
609-951-6800
<
Website: <
www.pharmanet.com
<
Ticker/ISIN: <
PDGI(NASDAQ)/US7171481002
<
Type of Organization: <
Public
<
Industry: <
Pharmaceutical
<
Key Executives: <
CEO: Jeffrey McMullen
<
CFO: John Hamill
<
Investor Relations <
Contact: <
Anne-Marie Hess
Phone: <
609-902-1169
Email: <
ahess@pharmanet.com
<
Investor Relations <
Contact: <
Mary Brickner
Phone: <
609-951-6976
Email: <
mbrickner@pharmanet.com
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion